Archive for April, 2008
« Previous EntriesDepression Turns Off The Music In The Mother-Baby Dance
Wednesday, April 30th, 2008Your newborn is crying. If it’s a cry of pain, you’re going to respond more strongly than you would to a cry of hunger - that’s the normal pattern. But if you suffer from post-partum depression, the difference between your response to the pain cry and the hunger cry is going to be even […]
Women & Depression
Tuesday, April 29th, 2008The National Alliance on Mental Illness (NAMI) has released a new brochure, Women and Depression, about the many dimensions of major depression in women. It can be downloaded at http://www.nami.org/womendepression. - 1 in 8 women experiences depression in their lifetime; twice the rate as men, regardless of race or ethnic background.
Deep Brain Stimulation May Offer Hope For Select Patients With Treatment Resistant Major Depression
Tuesday, April 29th, 2008Researchers from the Cleveland Clinic, Brown University, and Massachusetts General Hospital will present results of a long-term outcome study that builds on previous promising research, which has shown that deep brain stimulation (DBS) is a potentially effective treatment option for people with treatment resistant major depression.The World Health Organization rates major depression as the top […]
According To Research From The University Of Navarra, Smokers Have A 41% Higher Risk Of Suffering Depression
Friday, April 25th, 2008The risk of suffering depression increases 41% in smokers, in comparison with non-smokers. This was the conclusion of a study undertaken with 8,556 participants by scientists of the University of Navarra, in collaboration with the University of Las Palmas de Gran Canaria and the Harvard School of Public Health (USA), and which demonstrates, in a […]
Biovail Receives FDA Approval For Aplenzin (BVF-033) For The Treatment Of Depression
Friday, April 25th, 2008Biovail Corporation (NYSE: BVF) (TSX: BVF) announced that it has received Approval from the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for Aplenzin™ (formerly known as BVF-033), a once-daily formulation of bupropion hydrobromide developed by Biovail for the treatment of depression in adults.
Having A Baby Isn’t Blissful For All New Mothers
Thursday, April 24th, 2008For many women, the lovely images of life with a new baby don’t jive with their reality. Instead of feeling happy, they feel overwhelmed.University of New Hampshire researcher Kathleen Kendall-Tackett says there are a myriad of treatments available to new mothers experiencing postpartum depression. She is the author of a new monograph, “Non-Pharmacological Treatments for […]
Depression Research Employs Laser Dissection
Wednesday, April 23rd, 2008Chinese investigators from Hefei and Dutch researchers in Amsterdam have collaborated using for the first time a combination of new elegant methodology in Depression research. They used postmortem human brain tissue that was donated to the Netherlands Brain Bank for research purposes and investigated a region in the basal part of the brain, the hypothalamus, […]
Social Form Of Bullying Linked To Depression, Anxiety In Adults
Wednesday, April 23rd, 2008Spreading rumors and gossiping may not cause bruises or black eyes, but the psychological consequences of this social type of bullying could linger into early adulthood, a new University of Florida study shows.
How To Recognize The Signs And Symptoms Of Anxiety And Depressive Illnesses
Wednesday, April 23rd, 2008Each year more than 40 million Americans will suffer from an anxiety disorder and more than 19 million Americans will suffer with a depressive illness. The most common signs of anxiety and depression include feelings of being down or blue, phobias, uncontrollable worrying, poor concentration, […]
St. Jude Medical Awarded U.S. Patent For Neurostimulation Therapy For Depression
Tuesday, April 22nd, 2008St. Jude Medical, Inc. (NYSE:STJ) announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25. Brodmann Area 25 is a structure within the subcollosal gyrus region of the brain. It is the focus of […]
« Previous Entries